July 14,2006

Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs

Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.

Next Article Previous Article

Recent News

12/18/24 Crapo Statement at ITC Nominations Hearing
12/17/24 Crapo Statement on Meeting With HHS Secretary Nominee
12/17/24 Crapo Statement on Meeting With USTR Nominee
12/10/24 Crapo Statement on Meeting With Treasury Secretary Nominee
12/05/24 Crapo Statement on Announcement of Intent to Nominate Billy Long to Serve as IRS Commissioner